The Food and Drug Administration (FDA), in collaboration with the Johns Hopkins Center of Excellence in Regulatory Science and Innovation, is announcing a public workshop entitled ``Clinical Trials--Assessing Safety and Efficacy in Diverse Populations.'' The purpose of the meeting is to discuss approaches in clinical trial design and subgroup analyses for therapeutic product development and life-cycle management.
Document
Clinical Trials-Assessing Safety and Efficacy for Diverse Populations; Public Meeting; Request for Comments
The Food and Drug Administration (FDA), in collaboration with the Johns Hopkins Center of Excellence in Regulatory Science and Innovation, is announcing a public workshop entitl...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
80 FR 66909
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Clinical Trials-Assessing Safety and Efficacy for Diverse Populations; Public Meeting; Request for Comments,” thefederalregister.org (October 30, 2015), https://thefederalregister.org/documents/2015-27728/clinical-trials-assessing-safety-and-efficacy-for-diverse-populations-public-meeting-request-for-comments.